文献速递肺血管病与心包/心肌炎

肺动脉高压右心室表型在随访风险分层中的预后价值

Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up.
PubMed 文献 · Eur Heart J · 2026-01-01

该研究在意大利肺动脉高压网络11个中心前瞻性纳入确诊后6至12个月复评的肺动脉高压患者,基于超声心动图变量预先定义四种右心室扩张与右心室-肺动脉耦合表型,随访全因死亡中位3.7年。结果显示这些表型在所有ESC/ERS或REVEAL 2.0风险组中均有分布(高危组仅见表型3和4),且在各风险组内表型4识别预后更差的患者,表型1在中危组识别生存更好的患者。

要点

  • 超声心动图右心室表型可为肺动脉高压首次随访提供独立于临床风险分层的额外预后信息。
  • 表型4(重度右心室扩张伴RV-PA耦合不良,伴或不伴中度及以上三尖瓣反流)在各风险组中均提示预后更差。
  • 表型1(轻度右心室扩张伴RV-PA耦合保留)在中危组中识别生存更好的患者。

核心结论

  • 基于超声心动图的右心室重构与功能障碍表型,在肺动脉高压患者首次随访时提供独立于临床风险分层的额外预后信息。

研究设计与样本

  • 意大利肺动脉高压网络(IPHNET)11个中心前瞻性收集确诊后6至12个月复评的肺动脉高压患者数据。
  • 超声心动图变量预先组合定义四种右心室表型,随访全因死亡中位3.7年。

主要发现

  • 四种超声心动图表型存在于所有ESC/ERS或REVEAL 2.0风险组中,但高危组仅包括表型3和表型4。
  • 在每个风险组中,表型4识别预后更差的患者。
  • 在中危风险组中,表型1识别生存更好的患者。

关键数值与推荐

  • 表型1:轻度右心室扩张伴RV-PA耦合保留。
  • 表型2:轻度右心室扩张伴RV-PA耦合不良。
  • 表型3:重度右心室扩张伴RV-PA耦合保留。
  • 表型4:重度右心室扩张伴RV-PA耦合不良,伴或不伴中度及以上三尖瓣反流。

临床怎么用

  • 在肺动脉高压患者首次随访时,可结合超声心动图右心室表型与现有临床风险分层工具进行更精细的预后评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The aim of this study was to evaluate whether echocardiography-derived phenotypes describing different degrees of right ventricular (RV) remodelling and dysfunction add prognostic information to that of current risk stratification tools in patients with pulmonary arterial hypertension (PAH) at first follow-up. METHODS: In 11 centres of the Italian Pulmonary Hypertension NETwork (IPHNET), data were prospectively collected from patients with PAH who underwent re-evaluation between 6 and 12 months after diagnosis. Echocardiographic variables were combined a priori to define four phenotypes representing different degrees of RV dilatation and right ventricular-pulmonary arterial (RV-PA) coupling: a mildly dilated right ventricle with preserved RV-PA coupling defined phenotype-1; a mildly dilated right ventricle with poor RV-PA coupling defined phenotype-2; a severely dilated right ventricle with preserved RV-PA coupling defined phenotype-3; a severely dilated right ventricle with poor RV-PA coupling, either with or without tricuspid regurgitation of moderate degree or more, defined phenotype-4. Patients were followed up for all-cause death for a median of 3.7 years. RESULTS: These echocardiographic phenotypes were present in all European Society of Cardiology/European Respiratory Society or REVEAL 2.0 risk groups except for the high-risk groups, which included only phenotype-3 and phenotype-4. In each risk group, RV phenotype-4 identified patients with a poorer prognosis; RV phenotype-1 identified patients with better survival in intermediate risk groups. CONCLUSIONS: Echocardiography-derived phenotypes describing different degrees of RV remodelling and dysfunction provide prognostic information which is independent of and additional to the clinically defined risk in PAH patients at first follow-up.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ghio S, Badagliacca R, D'Alto M, et al. Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up. Eur Heart J. 2026. PMID: 41649944. doi:10.1093/eurheartj/ehag023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。